Background: Radiofrequency electromagnetic field (RFEMF or simply RF)-based
INTRODUCTION
Electrophysical agents (EPAs) have established themselves over the years as one of the pillars of therapy practice. They are used by clinicians all over the world to treat a wide variety of conditions. Many of these agents employ some form of electromagnetic fields (EMF), in which 'radiofrequency electromagnetic field' (RFEMF or simply RF) is a major component. Radiofrequency radiations constitute a significant part of the Electromagnetic Spectrum. The Institute of Electrical and Electronics Engineers Inc. (IEEE) define RF as EMF frequencies between 3 kHz-300 GHz. 1, 2 This is a broader spectrum compared to the usually referred frequency range of 30 kHz-300 MHz. 2 This paper aims to review the clinical evidence base for RF-based EPAs operating between the frequencies 30 kHz-30 MHz used in physical therapy practice. Research employing radiofrequency higher than 30 MHz is excluded from this review as it is seldom used in current therapy practice. 3 Though undetectable to the human senses, RF fields are omnipresent and have become an unavoidable part of our lives. Their ranges of applications are innumerable in areas such as communication, industry and healthcare. In medicine and surgery they play a key role in diagnosis, treatment and monitoring of several conditions. The RF literature pertaining to these areas in medical science is substantial, and is beyond the scope of this review.
Similarly, the literature base for the biological effects of RF fields is also extensive and a mature scientific discipline with over 60 years of history. 4 Hundreds of studies and numerous reviews have been published analysing the effects, benefits and hazards of RF on the biological systems, either due to intended or due to unintended exposure. Numerous studies describing the theoretical underpinning of RF-induced biological effects are also available. [4] [5] [6] [7] [8] Physiological responses to RF-tissue interaction in humans and the mechanisms 4 of actions believed to underpin such responses are well investigated. 4, 5, [7] [8] [9] Besides the extensive literature on the biological effects of high frequency RF (Microwaves: 300 MHz-300 GHz), a considerable proportion of studies deal with smaller RF bands that include the shortwaves (10-100 MHz) and frequencies below the shortwaves (30 kHz-10 MHz). These frequency bands are of particular interest in the therapy arena.
2, In physical therapy, the use of RF in EPAs has been reported since the early decades of last century. 56 Mainly three RF modalities were in use, which output contrasting frequencies in the RF spectrum. Longwave diathermy, which employs RF fields of around 0.5-1.0 MHz became obsolete in the 1950s owing to practical limitations and the severe disturbances it caused to communication and broadcasting. 57 Shortwave therapy (SWT) (also known as shortwave diathermy, or SWD) commonly operating at 27.12 MHz and Microwave therapy (also known as microwave diathermy, or MWD) operating at up to 2. 45 GHz became more established in practice. However, currently microwave therapy is used infrequently in many countries. 3, [58] [59] [60] Research pertaining to Microwave therapy and Longwave diathermy are excluded from this review.
Historically, SWT has employed several different frequencies, which are not the same in all countries. In 1947, the Federal Communication Commission of the United States Government assigned three frequencies at the short end of the RF band (40.68 MHz, 27.12
MHz and 13.56 MHz) for the medical use of shortwave in an attempt to regulate the use of high frequency currents in different disciplines. 61 These frequencies used relate to international regulation rather than known effectiveness. Of the three frequencies, 27.12
MHz is the most widely used in current clinical practice. Shortwave therapy is available in two modes: continuous (CSWT) and pulsed (PSWT). The CSWT has been widely used by clinicians since the 1930s, but has now become less popular and infrequently used in the western world. 3, 62 There is in fact an evidence base to support the use of CSWT, so the diminishing popularity is partly linked to a 'fashionable shift' rather than the evidence base per se. 9 In contrast, PSWT, which was developed in the 1940s and has since become the more popular delivery option, is in use among about 11% of outpatient clinics in the UK. 3, 62, 63 In the literature several synonymous terms can also be found alongside PSWT, such as pulsed electromagnetic energy (PEME), pulsed electromagnetic field (PEMF), pulsed high frequency electromagnetic energy (PHFE) or pulsed radiofrequency energy (PRFE) although the majority of such devices employ RF at 27.12 MHz. This is because some of the device manufacturers used such terms instead of the more generic PSWT. Throughout this review the authors will use the term pulsed shortwave therapy (PSWT) for consistency.
In addition to these three modalities, devices operating at significantly lower RF ranges (below 1 MHz) have also been reported and have become commercially available.
Nonetheless, the research in this area is sparse. The authors of this review identified a limited number of articles pertaining to this area. [46] [47] [48] 50, [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] The current literature (published in English) indicates that the RF used in therapy-related clinical practice is predominantly in the SWT band, and largely limited to PSWT as a delivery mode. 3, 9, 62, [78] [79] [80] Although several authors have reviewed the therapeutic effects of SWT as they are applied to various specific conditions, 56, 62, 79, [81] [82] [83] none covers all the therapy-related clinical literature in this frequency spectrum. No similar reviews are available on the clinical studies that have employed RF below the shortwave frequencies. Furthermore, only a limited 6 number of studies appear in the majority of the reviews identified, owing to their stringent inclusion criteria.
This paper aims to review all therapy-related clinical studies conducted on human patients covering the frequency range of 30 kHz-30 MHz and discuss the studies on acute conditions in detail. In addition, the authors identified several studies conducted on laboratory animals evaluating the effects of RF on experimentally-induced acute conditions. Although these studies are beyond the primary remit of this review, it may be of interest to illustrate some of the key issues in relation to the clinical studies. Hence, the RF studies performed on animals within the referred frequency range will be discussed here prior to the clinical literature.
Experimental studies on animals
Four animal studies on the effects of SWT on healing of acute wounds were identified; two on healing of skeletal muscle injuries 14, 15 and one each on bone injury 51 and skin wound. 16 One study each investigated the resolution of haematomas 17 and arthritis 20 with the application of PSWT. 
METHODS
The authors carried out electronic literature searches as well as hand searches of print journals to identify relevant articles. Electronic searches were carried out using the online bibliographic databases PubMed, Scopus, ISI Web of Science and CINAHL Plus. Google Scholar was also used as an additional source. Articles were also identified by further hand searches of the reference lists. References were managed using the EndNote X6 (Thomson Reuters) software package.
Primary searches carried out to identify relevant articles covered publications from all the years to date (January 2015). Key search words used were "Radiofrequency", "RF", "Electromagnet*", "EMF", "Shortwave", "SW" and "Diathermy", and alternate forms and combinations of these keywords. Further filtering was performed using additional search words "Biological", "Clinical", "Physiological" or "Therapeutic", and "effects". All articles dealing with the RF frequency range of 30 kHz-30 MHz were retained as a 'primary pool'.
This pool contained clinical, non-clinical, animal research, theoretical as well as review articles irrespective of the language, study type or methodology.
From among the clinical studies in this pool, all therapy-related clinical studies published in English and conducted solely on human patient(s) employing a non-invasive and nonablative methodology were selected for the review. Studies published in languages other than English, or conducted in healthy human subjects or in animals were excluded.
Additionally, studies needed to be conducted on patients in vivo pertaining to any clinical area within the realm of therapy and rehabilitation. As identified, some animal studies on RF have already been discussed in the introduction to illustrate some key issues. The inclusion/exclusion criteria stated above reflect the all-inclusive methodological approach 10 the authors have followed for the purpose of this review. This approach is dissimilar to that of a systematic review and does not exclude studies based on their methodological design and/or quality as would be the norm in a systematic review. It is not a novel approach and several examples of such reviews can be found in contemporary therapy literature.
85-88
The full-texts of the included studies were obtained. The studies were stratified on the basis of the frequency of RF used (shortwave, non-shortwave), the study design (clinical trial, as either 'zero' (insufficient power) or 'one' (sufficient power) was used in this review.
Hence, the maximum score that could be obtained by a study was 28.
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RESULTS
The flow of studies through the review is given in Figure 1 . A 'primary pool' of 588 articles within the frequency range 30 kHz-30 MHz was generated after the initial screening. Within this, 555 articles related to shortwave frequencies and 45 to non-shortwave frequencies.
Some (12 articles) covered frequency ranges that overlapped these nominal groupings.
From the primary pool 120 clinical studies met the inclusion criteria for the narrative review.
Among this, 112 were shortwave studies and eight were non-shortwave studies. Two potentially suitable studies employing shortwave were excluded as they had no proper abstracts and their full-texts were unavailable through our resources. 97, 98 Eighty nine studies were conducted on conditions relating to pain and inflammation and 23 on conditions relating to tissue healing. A further eight studies were classed as 'others' and related to a mixture of conditions that were relatively less reported (e.g. Acute pneumothorax).
However, as identified, the authors recognise that it is problematic to classify studies into such distinct clinical categories, given that they may overlap to a varied extent. Clearly there was potential overlap between studies that considered pain and inflammation and that considered tissue healing. For the purpose of this review, the allocation of a particular paper to a group was based on the primary outcome(s) as identified by their authors.
A total of 30 studies investigated acute clinical conditions and 90 investigated chronic clinical conditions. Although the overall results of the literature review have been presented here, this paper will discuss only the 30 studies on acute conditions. The studies on chronic conditions will be discussed in a future separate paper. The full texts were available for all the studies discussed here except for two. There appears to be a chronological gap in this category after which four randomised controlled trials (RCTs) have been reported recently on small wearable type RF generators.
Two studies 119, 121 on patients who had undergone breast augmentation surgery showed beneficial effects of such therapy in terms of reduced postoperative pain and reduced consumption of pain medication. In the first study by Heden and Pilla, 119 PSWT was delivered for 30 minutes 3-6 times daily for the first six days postoperatively; and then twice daily until the follow-up visit on day seven. In the second study by Rawe and colleagues, 121 PSWT was delivered continuously from postoperative day one till day seven.
Both studies were small and did not employ true control groups. In another small study, Rohde and colleagues 120 used a similar device and treatment regimen as Heden and Pilla, 119 but in patients who had undergone breast reduction surgery. They demonstrated a threefold drop in the pain scores of 12 actively treated patients compared to 12 placebo group patients. In this study, a reduction in interleukin 1-β levels of the wound exudate was also demonstrated, claiming an RF-induced modulation of the wound healing process. In a further study investigating the benefits of wearable PSWT devices, 122 57 patients who underwent bilateral upper blepharoplasty and received either an active or a placebo PSWT 17 device to their eyes did not report any difference between the two in terms of postoperative pain, oedema or ecchymosis. However, there was a statistically significant reduction in physician-graded erythema in actively treated eyes compared to the placebo.
The devices (active for one eye and placebo for the other) were worn for varying durations for up to one week postoperatively. However, both active and placebo groups also used cold patches where required, but this was not controlled or accounted for in the final analysis.
To conclude, among the studies that investigated the effects of RF on postoperative pain conditions, the majority have claimed significant benefits from RF therapy. All studies started the RF intervention either pre-operatively or immediately postoperatively. It may be noted ( Table 1 ) that the studies that reported no benefit from RF therapy have generally employed a lower dose and/or overall duration of intervention. However, because of the varied nature of dosage parameters used by the authors any potential range of ideal doses could not be identified. The results of the studies in this group need to be considered against their overall methodological quality, several of which were problematic, especially the earlier studies. The majority did not feature a true control group and failed to demonstrate sufficient statistical power or equivalence between the groups at baseline, which may serve to weaken their overall impact. Treatment of the epigastric area (over the liver) was employed by some earlier studies, as preceding studies performed on healthy adults 37, 128 had reported that it increased peripheral circulation. However, this practice became less popular in later years.
Acute ankle injuries
In an RCT by Wilson, 103 sixty minutes of PSWT administered for three consecutive days was shown to reduce pain and disability among patients (20 active, 20 placebo) who sustained acute ankle inversion injuries. The author obtained comparable results in a further study 105 that also employed CSWT and where methods similar to the first study were used.
Conversely, Pasila and colleagues 107 failed to demonstrate any significant difference in pain and swelling among 300 patients with recent ankle and foot injuries in a much larger study.
There were two active groups receiving two types of PSWT, and one placebo group.
Although the intervention in this study was similar to the study by Wilson, 103 On the whole, the evidence in this group was equivocal. The RF intervention commenced within 36 hours after the injury in all the studies except in two studies 107, 117 (within 3-4 19 days). 107, 117 In terms of trial quality, both groups of studies, which were either against or in favour of using RF, had several methodological shortcomings including a lack of sufficient statistical power, lack of baseline equivalence between the groups, lack of follow-up and high drop-out rates. Many studies did not report dosage parameters adequately and for others the doses were varied (Table 1) . However, where reported it may be noted that similar to the studies on postoperative pain, the studies on ankle injuries that reported no benefit from RF therapy employed a lower dose and/or overall duration of intervention.
Fracture pain
Only two studies were identified in this category. The first study published by Livesley and colleagues 116 investigated the effects of PSWT (30 minutes daily for 10 consecutive days) in the management of fracture of the neck of humerus. Forty eight patients (22 active, 26 placebo) were treated and followed-up for up to six months. No significant difference was found between the groups either for pain or for functional scores at any stage. In the second study by Buzzard and colleagues, 118 twenty patients presented to a trauma unit with unilateral calcaneal fractures were treated either by PSWT (15 minutes twice daily for five days) or by ice therapy ('Cryocuff' for 20 minutes, six times a day for five days). Daily measurements of swelling and ankle ROM showed significant improvement in both groups with no significant difference between the groups. Like several previously discussed studies, both trials had limited statistical power, lacked a true control group and did not demonstrate sufficient equivalence between the groups at baseline. While the dosage parameters were inadequately reported in the first study, the second employed a very low mean dose of PSWT (Table 1) , which arguably was too low to be clinically effective.
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Other acute conditions with pain
A case series on the PSWT management of soft tissue injuries in professional footballers was published by Wright in 1973. 104 A rapid reduction in intra-muscular haematoma was reported with repeated daily PSWT for up to a week. In a later clinical trial by Nwuga, 108 51 female patients suffering from acute low back pain were treated with either CSWT (20 minutes thrice weekly) or spinal manipulation, for up to six weeks. The study showed that manipulation was superior to CSWT in terms of improving the spinal and pelvic range of movement (ROM). The study, however, did not objectively assess pain or outcomes of functional quality of life of the participants. Also, there were no follow-up assessments. The generalizability of these findings is limited, as only female subjects were included.
Similarly, 414 women recovering from pelvic trauma (sustained during childbirth) who were studied in four groups (PSWT, ultrasound, placebo-PSWT or placebo-ultrasound) by Grant and colleagues 114 did not demonstrate any significant difference between the groups at the end of treatment. The PSWT treatment was given for 10 minutes daily for three days.
Although this was a large trial with adequate statistical power, a true control group was absent and the outcome measures employed were predominantly subjective in nature. In another large trial by Barclay and colleagues 109 on 230 patients who had sustained hand injuries, 114 active group participants who were treated by PSWT (30 minutes twice daily for up to seven days) showed marked reduction in pain, swelling and disability over 116 control group participants. Similarly, in a well-designed study by Foley-Nolan and colleagues, 115 20 patients who had sustained acute whiplash injuries treated with PSWT (RF generating collar worn for eight hours daily for 12 weeks) reported significant improvement in pain compared 20 placebo-treated patients. 21 This group contained a mixture of studies, which have mostly reported favourable results for the use of PSWT. As with other groups of studies on pain and inflammation, methodological shortcomings (absence of true control group, lack of follow-up, subjectivity of outcome measures) and lack of adequate reporting (statistical power, dose parameters)
were apparent.
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STUDIES ON TISSUE HEALING
Out of the seven studies included in this category, five were on healing of postoperative wounds, 99, 100, [123] [124] [125] and one each on bone healing, 84 and healing of lacerated wounds of the lower limb. 126 All studies used devices delivering RF energy at a frequency of 27.12 MHz.
Postoperative wound healing
Five studies examined the effects of SWT on healing of postoperative wounds, of which four were clinical trials 99, 100, 123, 124 and one cohort study. 125 In a double-blinded RCT Bentall and None of the trials discussed in this category employed both placebo and control conditions and many failed to establish adequate equivalence between the study groups at baseline.
All studies started the RF intervention either pre-operatively or immediately postoperatively. Similar to the studies on postoperative pain, the dosage parameters where reported remained varied, hence any commonalities could not be drawn.
Other studies on tissue healing
A study by Cameron 84 reported favourable results with PSWT in bone and soft tissue injuries. In a mixed design research project containing three separate studies, a total of 646 surgical and non-surgical orthopaedic patients benefitted from PSWT (20 minutes over the liver and 20 minutes over the wound, twice daily for four days). However, despite the presence of a large sample, the study lacked a properly randomised methodological design, and no standardised outcome measures were used for assessment. In 1991, Muirhead and colleagues 126 reported an RCT of 129 patients who had sustained lower limb injuries (pretibial lacerations). Sixty six patients in the active group received PSWT (10 minutes three times a week) in addition to standard wound dressing. Contrary to the studies discussed previously, there was no evidence of accelerated wound healing. This study failed to reach adequate statistical power and had a high participant drop-out rate, which was not accounted for in the analysis.
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STUDIES ON OTHER APPLICATIONS
While the vast majority of RF research in the acute clinical area is centred on applications for reducing pain and inflammation, and some others for tissue healing, only one study was identified, which investigated the effects of RF on other acute conditions. In a blinded RCT, Ma and colleagues 127 studied 22 patients with pneumothoraces of less than 30% volume, in two groups. One group received a daily dose of CSWT for 25 minutes (at an intensity causing 'just perceptible warmth'). The control group participants were kept under observation with only bed rest. The time to lung re-expansion was found to be significantly shorter in the CSWT group compared to the bed rest group (3-12.5 days and 8-17 days respectively). The study, however, is unlikely to have had sufficient statistical power (unreported) with only 11 subjects per treatment arm. Although this trial was published in 1997 and the results were encouraging, no further studies on this condition have been reported since. tissue healing or other less reported conditions is sparse and conflicting. 26 The evidence reported in this review may only be considered against the overall quality of the included studies, which was mixed. An apparent lack of robustness and integrity in the methodological designs, and infrequent reporting of the RF dosage parameters, outcomes and statistical analysis made the assessment of results problematic for many studies. A lack of consistency in reporting was particularly evident in the earlier studies. Where doses were reported, the rationale for selection was unclear. Additionally, poor baseline equivalence between study groups was often evident; and participant drop-outs, which were sometimes high were not accounted for in the final analysis (no intention-to-treat analysis) as would be the norm in current publications. Owing to the varied nature of methods, outcomes and interventions of the included studies, it has not been possible to compare and draw any commonalities between them.
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CONCLUSIONS
Although RF-based therapy has been in use for almost a century, therapy-related clinical research in this area is still scant, with only limited number of studies published on acute clinical conditions. The types of such clinical conditions studied for the effects of RF-based therapy are even more limited. Clearly there is a need for further research in this area. Even though this review considered studies from the frequency of 30 kHz and above, no studies on acute conditions employing RF below the shortwave frequency of 27.12 MHz were identified. On the whole, a lack of research in the non-shortwave RF band is evident, with studies on acute conditions almost non-existent. This warrants research emphasis in this area especially since devices delivering non-shortwave RF have long been used in therapy. 
